| PAT. NO. | Title |
|---|
| 8,367,643 |
Surfactant lipids, compositions thereof and uses thereof |
| 8,178,098 |
Method to Inhibit Airway Hyperresponsiveness Using Aerosolized T Cell Receptor Antibodies |
| 8,101,361 |
Markers for Diagnosis of Pulmonary Inflammation and Methods Related Thereto |
| 8,158,107 |
Genes and Proteins Associated With Angiogenesis and Uses Thereof |
| 8,101,361 |
Markers for Diagnosis of Pulmonary Inflammation and Methods Related Thereto |
| 8,058,396 |
Cystatin C as an Antagonist of TGF-β and Methods Related Thereto |
| 7,999,082 |
Anti-factor B antibodies |
| 7,994,115 |
Three Dimensional Structures of TALL-1 and its Cognate Receptors Related Thereto and Uses and Molecules |
| 7,825,224 |
Product and method for treatment of conditions associated with receptor-desensitization |
| 7,825,089 |
Three-dimensional structures of TALL-1 |
| 7,772,011 |
Method and kit for detection of autoimmune chronic urticaria |
| 7,754,705 |
Cationic steroid antimicrobial compositions and methods of use |
| 7,741,300 |
Methods of using nucleic acid vector-lipid complexes |
| 7,749,958 |
Cystatin C as an antagonist of TGF-.beta. and methods related thereto |
| 7,582,300 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
| 7,534,438 |
Product and process for liquefaction of mucus or sputum |
| 7,498,047 |
Methods for treatment of thiol-containing compound deficient conditions |
| 7,468,048 |
Joint aspirate facilitating device |
| 7,374,934 |
Cell populations and methods of production thereof |
| 7,282,477 |
Cystatin C as an antagonist of TGF-.beta. and methods related thereto |
| 7,189,707 |
Substituted porphyrins |
| 7,169,570 |
Method to identify regulators of cellular activation using Bcl10 |
| 7,160,681 |
Method for regulating cell growth and assays related thereto |
| 7,090,865 |
Composition and method for treating autoimmune hemolytic anemia |
| 6,951,733 |
Method for testing drug susceptibility of Mycobacterium tuberculosis |
| 6,916,799 |
Substituted Porphyrins |
| 6,875,749 |
Methods for facilitating vascular growth |
| 6,737,398 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
| 6,693,086 |
Systemic immune activation method using nucleic acid-lipid complexes |
| 6,579,694 |
Agar medium for the growth of Mycobacterium tuberculosis |
| 6,576,433 |
Method for identification of cell growth or differentiation factors |
| 6,555,318 |
Method for identification of cell growth or differentiation factors |
| 6,544,975 |
Substituted porphyrins |
| 6,503,509 |
Method for receptor desensitization |
| 6,497,840 |
Ultraviolet germicidal system |
| 6,479,477 |
Substituted porphyrins |
| 6,475,987 |
Tall-1 receptor homologues |
| 6,399,607 |
Aminomethylene amide analogs of pyrazinamide with intracellular antimycobacterial activity against pyrazinamide-resistant mycobacteria combined with a rifamycin |
| 6,333,170 |
Method and product for regulating cell responsiveness to external signals |
| 6,306,612 |
Methods of facilitating vascular growth |
| 6,264,888 |
Ultraviolet germicidal apparatus and method |
| 6,231,894 |
Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
| 6,187,584 |
Products and processes for regulation of gene recombination |
| 6,156,503 |
Diagnosing asthma patients predisposed to adverse.beta.-agonist reactions |
| 6,110,739 |
Method to produce novel embryonic cell populations |
| 6,074,861 |
MEKK proteins |
| 6,040,152 |
Method and assay for regulation of T cell proliferation |
| 5,985,261 |
Use of thioredoxin-like molecules for induction of MnSOD to treat oxidative damage |
| 5,981,265 |
Methods for regulating MEKK protein activity |
| 5,959,074 |
Products and processes for regulation of gene recombination |
| 5,935,568 |
Gene therapy for effector cell regulation |
| 5,914,268 |
Embryonic cell populations and methods to isolate such populations |
| 5,874,301 |
Embryonic cell populations and methods to isolate such populations |
| 5,820,866 |
Product and process for T cell regulation |
| 5,405,941 |
MEKK protein, capable of phosphorylating MEK |
